Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of ARS 259.08 trillion. The enterprise value is 324.43 trillion.

Market Cap	259.08T
Enterprise Value	324.43T

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	81.91%
Float	538.24M

Valuation Ratios

The trailing PE ratio is 23.15 and the forward PE ratio is 15.24.

PE Ratio	23.15
Forward PE	15.24
PS Ratio	4.86
PB Ratio	20.62
P/TBV Ratio	n/a
P/FCF Ratio	22.04
P/OCF Ratio	17.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 27.60.

EV / Earnings	28.99
EV / Sales	6.26
EV / EBITDA	13.63
EV / EBIT	19.86
EV / FCF	27.60

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.36%
Revenue Per Employee	1.69B
Profits Per Employee	355.29M
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.84 trillion in taxes.

Income Tax	1.84T
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +53.39% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+53.39%
50-Day Moving Average	17,647.20
200-Day Moving Average	15,671.38
Relative Strength Index (RSI)	49.67
Average Volume (20 Days)	1,570

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.69

Income Statement

In the last 12 months, Amgen had revenue of ARS 53.34 trillion and earned 11.19 trillion in profits. Earnings per share was 20,653.42.

Revenue	53.34T
Gross Profit	37.76T
Operating Income	16.80T
Pretax Income	13.03T
Net Income	11.19T
EBITDA	24.12T
EBIT	16.80T
Earnings Per Share (EPS)	20,653.42

Balance Sheet

The company has 13.25 trillion in cash and 80.46 trillion in debt, giving a net cash position of -67,208.53 billion.

Cash & Cash Equivalents	13.25T
Total Debt	80.46T
Net Cash	-67,208.53B
Net Cash Per Share	n/a
Equity (Book Value)	12.57T
Book Value Per Share	23,322.61
Working Capital	5.18T

Cash Flow

In the last 12 months, operating cash flow was 14.45 trillion and capital expenditures -2,696.70 billion, giving a free cash flow of 11.76 trillion.

Operating Cash Flow	14.45T
Capital Expenditures	-2,696.70B
Depreciation & Amortization	7.08T
Net Borrowing	-7,983.40B
Free Cash Flow	11.76T
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 274.80, which amounts to a dividend yield of 1.60%.

Dividend Per Share	274.80
Dividend Yield	1.60%
Dividend Growth (YoY)	43.15%
Years of Dividend Growth	15
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	1.42%
Earnings Yield	4.32%
FCF Yield	4.54%

Dividend Details

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 3.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	3

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7